These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27005318)

  • 1. Skeletal Characteristics of WNT1 Osteoporosis in Children and Young Adults.
    Mäkitie RE; Haanpää M; Valta H; Pekkinen M; Laine CM; Lehesjoki AE; Schalin-Jäntti C; Mäkitie O
    J Bone Miner Res; 2016 Sep; 31(9):1734-42. PubMed ID: 27005318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired WNT signaling and the spine-Heterozygous WNT1 mutation causes severe age-related spinal pathology.
    Mäkitie RE; Niinimäki T; Nieminen MT; Schalin-Jäntti C; Niinimäki J; Mäkitie O
    Bone; 2017 Aug; 101():3-9. PubMed ID: 28411110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered MicroRNA Profile in Osteoporosis Caused by Impaired WNT Signaling.
    Mäkitie RE; Hackl M; Niinimäki R; Kakko S; Grillari J; Mäkitie O
    J Clin Endocrinol Metab; 2018 May; 103(5):1985-1996. PubMed ID: 29506076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in WNT1 cause different forms of bone fragility.
    Keupp K; Beleggia F; Kayserili H; Barnes AM; Steiner M; Semler O; Fischer B; Yigit G; Janda CY; Becker J; Breer S; Altunoglu U; Grünhagen J; Krawitz P; Hecht J; Schinke T; Makareeva E; Lausch E; Cankaya T; Caparrós-Martín JA; Lapunzina P; Temtamy S; Aglan M; Zabel B; Eysel P; Koerber F; Leikin S; Garcia KC; Netzer C; Schönau E; Ruiz-Perez VL; Mundlos S; Amling M; Kornak U; Marini J; Wollnik B
    Am J Hum Genet; 2013 Apr; 92(4):565-74. PubMed ID: 23499309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal characteristics associated with homozygous and heterozygous WNT1 mutations.
    Palomo T; Al-Jallad H; Moffatt P; Glorieux FH; Lentle B; Roschger P; Klaushofer K; Rauch F
    Bone; 2014 Oct; 67():63-70. PubMed ID: 25010833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective WNT signaling associates with bone marrow fibrosis-a cross-sectional cohort study in a family with WNT1 osteoporosis.
    Mäkitie RE; Niinimäki R; Kakko S; Honkanen T; Kovanen PE; Mäkitie O
    Osteoporos Int; 2018 Feb; 29(2):479-487. PubMed ID: 29147753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.
    Välimäki VV; Mäkitie O; Pereira R; Laine C; Wesseling-Perry K; Määttä J; Kirjavainen M; Viljakainen H; Välimäki MJ
    J Clin Endocrinol Metab; 2017 Feb; 102(2):535-544. PubMed ID: 27732335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel missense loss-of-function mutations of WNT1 in an autosomal recessive Osteogenesis imperfecta patient.
    Won JY; Jang WY; Lee HR; Park SY; Kim WY; Park JH; Kim Y; Cho TJ
    Eur J Med Genet; 2017 Aug; 60(8):411-415. PubMed ID: 28528193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta.
    Laine CM; Joeng KS; Campeau PM; Kiviranta R; Tarkkonen K; Grover M; Lu JT; Pekkinen M; Wessman M; Heino TJ; Nieminen-Pihala V; Aronen M; Laine T; Kröger H; Cole WG; Lehesjoki AE; Nevarez L; Krakow D; Curry CJ; Cohn DH; Gibbs RA; Lee BH; Mäkitie O
    N Engl J Med; 2013 May; 368(19):1809-16. PubMed ID: 23656646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous WNT1 variant causing a variable bone phenotype.
    Alhamdi S; Lee YC; Chowdhury S; Byers PH; Gottschalk M; Taft RJ; Joeng KS; Lee BH; Bird LM
    Am J Med Genet A; 2018 Nov; 176(11):2419-2424. PubMed ID: 30246918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective WNT signaling may protect from articular cartilage deterioration - a quantitative MRI study on subjects with a heterozygous WNT1 mutation.
    Lehtovirta S; Mäkitie RE; Casula V; Haapea M; Niinimäki J; Niinimäki T; Peuna A; Lammentausta E; Mäkitie O; Nieminen MT
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1636-1646. PubMed ID: 31299386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis.
    Joeng KS; Lee YC; Lim J; Chen Y; Jiang MM; Munivez E; Ambrose C; Lee BH
    J Clin Invest; 2017 Jun; 127(7):2678-2688. PubMed ID: 28628032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations.
    Joeng KS; Lee YC; Jiang MM; Bertin TK; Chen Y; Abraham AM; Ding H; Bi X; Ambrose CG; Lee BH
    Hum Mol Genet; 2014 Aug; 23(15):4035-42. PubMed ID: 24634143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutation G324C in WNT1 mapped in a large Pakistani family with severe recessively inherited Osteogenesis Imperfecta.
    Kausar M; Siddiqi S; Yaqoob M; Mansoor S; Makitie O; Mir A; Khor CC; Foo JN; Anees M
    J Biomed Sci; 2018 Nov; 25(1):82. PubMed ID: 30447692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in WNT1 are a cause of osteogenesis imperfecta.
    Fahiminiya S; Majewski J; Mort J; Moffatt P; Glorieux FH; Rauch F
    J Med Genet; 2013 May; 50(5):345-8. PubMed ID: 23434763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.
    Mäkitie RE; Kämpe A; Costantini A; Alm JJ; Magnusson P; Mäkitie O
    J Bone Miner Res; 2020 May; 35(5):901-912. PubMed ID: 31968132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel WNT1 mutations in children with osteogenesis imperfecta: Clinical and functional characterization.
    Lu Y; Ren X; Wang Y; Bardai G; Sturm M; Dai Y; Riess O; Zhang Y; Li H; Li T; Zhai N; Zhang J; Rauch F; Han J
    Bone; 2018 Sep; 114():144-149. PubMed ID: 29935254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The brains of the bones: how osteocytes use WNT1 to control bone formation.
    Rauch F
    J Clin Invest; 2017 Jun; 127(7):2539-2540. PubMed ID: 28628035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: Early-onset osteoporosis in a patient carrying a novel heterozygous variant of the
    Campopiano MC; Fogli A; Michelucci A; Mazoni L; Longo A; Borsari S; Pardi E; Benelli E; Sardella C; Pierotti L; Dinoi E; Marcocci C; Cetani F
    Front Endocrinol (Lausanne); 2022; 13():918682. PubMed ID: 36004351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.